EUVIMEDΑνακαλύψτε το EUVIMED
Leserbrief

Comment on “Aldosterone Synthase Inhibition in Kidney Transplantation: Class Rationale, Translational Promise, and the Limits of Current Evidence”

Shubham Singh, Sharill Bhardwaj, Arun Kumar Sharma

Clinical Transplantation · 2026-11 · 40 (11)

DOI: 10.1111/ctr.70700 ↗

At a glance

Leserbrief in Clinical Transplantation, published online on 2026-11-17. Written by Shubham Singh and 2 co-authors. Institution: Department of Pharmaceutics, ISF College of Pharmacy, Moga, Punjab, India. 5 references.

ΠερίληψηSubjectsΒιβλιογραφικά στοιχείαCiteRelated studies

Abstract (original language)

Δεν υπάρχει διαθέσιμη περίληψη.

Subjects

Author keywords

aldosterone synthase inhibitionambulatory blood pressure monitoringcalcineurin inhibitorshyperkalemiakidney transplantationrenin–angiotensin systemresistant hypertensionthiazide diuretics

Authors and institutions

  • Department of Pharmaceutics, ISF College of Pharmacy, Moga, Punjab, India.
  • Faculty of Pharmaceutical Sciences, DAV University, Punjab, India.
  • Department of Pharmacology, ISF College of Pharmacy, Moga, Punjab, India.

Cite

APA

Singh, S., Bhardwaj, S., & Sharma, A. K. (2026). Comment on “Aldosterone Synthase Inhibition in Kidney Transplantation: Class Rationale, Translational Promise, and the Limits of Current Evidence”. Clinical Transplantation, 40(11). https://doi.org/10.1111/ctr.70700

Vancouver

Singh S, Bhardwaj S, Sharma AK. Comment on “Aldosterone Synthase Inhibition in Kidney Transplantation: Class Rationale, Translational Promise, and the Limits of Current Evidence”. Clinical Transplantation. 2026;40(11). doi:10.1111/ctr.70700

BibTeX
@article{Singh2026,
  author = {Singh, Shubham and Bhardwaj, Sharill and Sharma, Arun Kumar},
  title = {Comment on “Aldosterone Synthase Inhibition in Kidney Transplantation: Class Rationale, Translational Promise, and the Limits of Current Evidence”},
  journal = {Clinical Transplantation},
  year = {2026},
  volume = {40},
  number = {11},
  doi = {10.1111/ctr.70700}
}
Start for free →